Home » Stocks » SOLY

Soliton, Inc. (SOLY)

Stock Price: $11.11 USD 0.45 (4.22%)
Updated Jan 26, 2021 4:00 PM EST - Market closed
After-hours: $11.00 -0.11 (-0.99%) Jan 26, 7:49 PM
Market Cap 235.42M
Revenue (ttm) n/a
Net Income (ttm) -13.27M
Shares Out 21.06M
EPS (ttm) -0.74
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 26
Last Price $11.11
Previous Close $10.66
Change ($) 0.45
Change (%) 4.22%
Day's Open 11.44
Day's Range 10.56 - 11.48
Day's Volume 393,133
52-Week Range 6.02 - 14.55

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
PRNewsWire - 18 hours ago

HOUSTON, Jan. 26, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced it...

PRNewsWire - 3 weeks ago

HOUSTON, Dec. 30, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced th...

Seeking Alpha - 2 months ago

Soliton, Inc. (SOLY) CEO Brad Hauser on Q3 2020 Results - Earnings Call Transcript

PRNewsWire - 2 months ago

HOUSTON, Nov. 12, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today reported fin...

PRNewsWire - 2 months ago

HOUSTON, Nov. 2, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today ann...

PRNewsWire - 2 months ago

HOUSTON, Oct. 27, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today an...

PRNewsWire - 3 months ago

HOUSTON, Oct. 5, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today ann...

PRNewsWire - 4 months ago

HOUSTON, Sept. 8, 2020 /PRNewswire/ -- Soliton, Inc.

PRNewsWire - 5 months ago

HOUSTON, Aug. 26, 2020 /PRNewswire/ -- Soliton, Inc.

PRNewsWire - 5 months ago

HOUSTON, Aug. 20, 2020 /PRNewswire/ -- Soliton, Inc.

PRNewsWire - 5 months ago

HOUSTON, Aug. 13, 2020 /PRNewswire/ -- Soliton, Inc.

Seeking Alpha - 5 months ago

Soliton, Inc.'s (SOLY) CEO Chris Capelli on Q2 2020 Results - Earnings Call Transcript

PRNewsWire - 5 months ago

HOUSTON, Aug. 11, 2020 /PRNewswire/ -- Soliton, Inc.

PRNewsWire - 5 months ago

HOUSTON, Aug. 5, 2020 /PRNewswire/ -- Soliton, Inc.

PRNewsWire - 5 months ago

HOUSTON, July 29, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, announced today th...

PRNewsWire - 6 months ago

HOUSTON, July 22, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today an...

Zacks Investment Research - 6 months ago

Soliton (SOLY) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.

Seeking Alpha - 6 months ago

Stock is down nearly 50% in the last few weeks, as a massive share offering well below where the stock was trading sparked selling.

PRNewsWire - 7 months ago

HOUSTON, June 26, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced th...

PRNewsWire - 7 months ago

HOUSTON, June 25, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced th...

Zacks Investment Research - 7 months ago

Soliton (SOLY) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

Seeking Alpha - 8 months ago

Soliton's (SOLY) CEO Chris Capelli on Q1 2020 Results - Earnings Call Transcript

PRNewsWire - 8 months ago

HOUSTON, May 14, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today reported fina...

Seeking Alpha - 11 months ago

Soliton: A Solid Play On The Tattoo Removal Opportunity In 2020

InvestorPlace - 1 year ago

These 5 stocks all have a real chance of winding up at zero — but if they can avoid that outcome, they could easily triple or more.

Other stocks mentioned: ACB, CHK, GCI, RAD
Seeking Alpha - 1 year ago

Soliton is developing a breakthrough technology for tattoo removal and cellulite treatment which will save time and money and have a higher degree of efficiency.

The Motley Fool - 1 year ago

The roller coaster ride continues.

Benzinga - 1 year ago

Medical device company Soliton Inc. (NASDAQ: SOLY) shares are trading higher again after the company highlighted its preclinical results for its new RAP device, which "is a potentially importa...

The Motley Fool - 1 year ago

The company is riding high following FDA clearance for its tattoo removal medical device.

Benzinga - 1 year ago

Medical device company Soliton Inc. shares are trading higher again after the company announced its decision to move forward with a pivotal trial after positive data from its proof-of-concept ...

InvestorPlace - 1 year ago

Approval from the U.S. Food and Drug Administration (FDA) for a Soliton tattoo removal device has SOLY stock on the rise Wednesday.

Benzinga - 1 year ago

Medical device company Soliton Inc. has received FDA 510(k) approval for its acoustic wave device for dermal tattoo clearing.

Seeking Alpha - 1 year ago

There is no guarantee Soliton’s RAP technology will be able to penetrate the tattoo removal market.

About SOLY

Soliton, a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. The company offers product for the removal of tattoos. It also develops product for cellulite reduction, fibrotic scar treatment, and other indications. The company was founded in 2012 and is based in Houston, Texas.

Industry
Medical Devices
IPO Date
Feb 19, 2019
Stock Exchange
NASDAQ
Ticker Symbol
SOLY
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 3 analysts, the average rating for Soliton stock is "Buy." The 12-month stock price forecast is 16.00, which is an increase of 44.01% from the latest price.

Price Target
$16.00
(44.01% upside)
Analyst Consensus: Buy